Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus operating margin
Operating margin is operating income as a percentage of revenue.
Agenus's operating margin for the twelve months ending Jun 30, 2026 was 27.3%. For fiscal 2025 it was -17.7%, against -116.4% the year before. The highest annual figure on record is 8.7% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -17.7% | +98.8 |
| FY2024 | Dec 31, 2024 | -116.4% | −14.4 |
| FY2023 | Dec 31, 2023 | -102.1% | +81.0 |
| FY2022 | Dec 31, 2022 | -183.0% | −191.8 |
| FY2021 | Dec 31, 2021 | 8.7% | +141.7 |
| FY2020 | Dec 31, 2020 | -133.0% | −86.2 |
| FY2019 | Dec 31, 2019 | -46.7% | +289.9 |
| FY2018 | Dec 31, 2018 | -336.6% | −94.5 |
| FY2017 | Dec 31, 2017 | -242.1% | +234.0 |
| FY2016 | Dec 31, 2016 | -476.1% | −150.9 |
| FY2015 | Dec 31, 2015 | -325.2% | +295.7 |
| FY2014 | Dec 31, 2014 | -620.9% | +199.4 |
| FY2013 | Dec 31, 2013 | -820.3% | −778.1 |
| FY2012 | Dec 31, 2012 | -42.2% | +650.4 |
| FY2011 | Dec 31, 2011 | -692.6% | −45.1 |
| FY2010 | Dec 31, 2010 | -647.5% | +182.6 |
| FY2009 | Dec 31, 2009 | -830.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 32.7% | +97.8 |
| Q1 FY2026 | Mar 31, 2026 | 44.6% | +99.9 |
| Q4 FY2025 | Dec 31, 2025 | 42.1% | +138.6 |
| Q3 FY2025 | Sep 30, 2025 | -15.0% | +110.4 |
| Q2 FY2025 | Jun 30, 2025 | -65.0% | +63.4 |
| Q1 FY2025 | Mar 31, 2025 | -55.3% | +62.1 |
| Q4 FY2024 | Dec 31, 2024 | -96.5% | −91.5 |
| Q3 FY2024 | Sep 30, 2024 | -125.5% | +65.1 |
| Q2 FY2024 | Jun 30, 2024 | -128.4% | +87.7 |
| Q1 FY2024 | Mar 31, 2024 | -117.4% | +119.9 |
| Q4 FY2023 | Dec 31, 2023 | -5.0% | +198.5 |
| Q3 FY2023 | Sep 30, 2023 | -190.6% | −7.7 |
| Q2 FY2023 | Jun 30, 2023 | -216.1% | −3.1 |
| Q1 FY2023 | Mar 31, 2023 | -237.3% | −100.6 |
| Q4 FY2022 | Dec 31, 2022 | -203.5% | +63.2 |
| Q3 FY2022 | Sep 30, 2022 | -182.9% | −257.0 |
| Q2 FY2022 | Jun 30, 2022 | -213.0% | +405.8 |
| Q1 FY2022 | Mar 31, 2022 | -136.7% | +216.3 |
| Q4 FY2021 | Dec 31, 2021 | -266.7% | −197.2 |
| Q3 FY2021 | Sep 30, 2021 | 74.1% | +308.7 |
| Q2 FY2021 | Jun 30, 2021 | -618.8% | −495.3 |
| Q1 FY2021 | Mar 31, 2021 | -353.0% | −171.5 |
| Q4 FY2020 | Dec 31, 2020 | -69.4% | −13.6 |
| Q3 FY2020 | Sep 30, 2020 | -234.6% | −54.4 |
| Q2 FY2020 | Jun 30, 2020 | -123.5% | +138.3 |
| Q1 FY2020 | Mar 31, 2020 | -181.5% | −214.3 |
| Q4 FY2019 | Dec 31, 2019 | -55.9% | +555.3 |
| Q3 FY2019 | Sep 30, 2019 | -180.2% | +23.5 |
| Q2 FY2019 | Jun 30, 2019 | -261.8% | −157.6 |
| Q1 FY2019 | Mar 31, 2019 | 32.8% | +2584.7 |
| Q4 FY2018 | Dec 31, 2018 | -611.1% | −252.1 |
| Q3 FY2018 | Sep 30, 2018 | -203.7% | +739.0 |
| Q2 FY2018 | Jun 30, 2018 | -104.3% | +582.2 |
| Q1 FY2018 | Mar 31, 2018 | -2551.9% | −2502.7 |
| Q4 FY2017 | Dec 31, 2017 | -359.0% | −6.1 |
| Q3 FY2017 | Sep 30, 2017 | -942.7% | −127.9 |
| Q2 FY2017 | Jun 30, 2017 | -686.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -49.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -352.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -814.8% | – |
See a number that looks wrong?